Aster DM Healthcare Limited (ASTERDM.BO)
INR 473.5
(-1.81%)
INR 473.5
(-1.81%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 6.11 Billion INR | -64.86% |
| 2022 | 10.61 Billion INR | 7.19% |
| 2021 | 15.83 Billion INR | 35.92% |
| 2020 | 11.52 Billion INR | -9.64% |
| 2019 | 13.06 Billion INR | 42.67% |
| 2018 | 9.21 Billion INR | 26.63% |
| 2017 | 8.09 Billion INR | 24.5% |
| 2016 | 8.01 Billion INR | 22.21% |
| 2015 | 4.85 Billion INR | -11.8% |
| 2014 | 5.41 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 2.52 Billion INR | 18.86% |
| 2024 Q1 | 1.63 Billion INR | 190.81% |
| 2023 Q4 | 1.59 Billion INR | -71.73% |
| 2023 FY | - INR | -64.86% |
| 2023 Q2 | 3.78 Billion INR | -2.83% |
| 2023 Q3 | 5.63 Billion INR | 48.89% |
| 2023 Q1 | 3.89 Billion INR | -25.13% |
| 2022 Q3 | 4.58 Billion INR | 35.87% |
| 2022 Q1 | 3.28 Billion INR | -31.53% |
| 2022 FY | - INR | 7.19% |
| 2022 Q4 | 5.2 Billion INR | 13.57% |
| 2022 Q2 | 3.37 Billion INR | 2.5% |
| 2021 FY | - INR | 35.92% |
| 2021 Q1 | 2.89 Billion INR | -20.35% |
| 2021 Q2 | 3.52 Billion INR | 21.73% |
| 2021 Q4 | 4.8 Billion INR | 17.43% |
| 2021 Q3 | 4.09 Billion INR | 15.93% |
| 2020 Q1 | 1.5 Billion INR | -60.94% |
| 2020 Q4 | 3.64 Billion INR | 8.77% |
| 2020 Q3 | 3.34 Billion INR | 19.51% |
| 2020 FY | - INR | -9.64% |
| 2020 Q2 | 2.8 Billion INR | 86.34% |
| 2019 Q4 | 3.84 Billion INR | -1.16% |
| 2019 Q2 | 2.49 Billion INR | 10.26% |
| 2019 Q1 | 2.26 Billion INR | -32.7% |
| 2019 Q3 | 3.89 Billion INR | 56.19% |
| 2019 FY | - INR | 42.67% |
| 2018 Q1 | 1.45 Billion INR | -46.52% |
| 2018 FY | - INR | 26.63% |
| 2018 Q4 | 3.35 Billion INR | 26.64% |
| 2018 Q3 | 2.65 Billion INR | 88.23% |
| 2018 Q2 | 1.4 Billion INR | -3.39% |
| 2017 FY | - INR | 24.5% |
| 2017 Q3 | 1.91 Billion INR | 29.4% |
| 2017 Q4 | 2.72 Billion INR | 42.67% |
| 2017 Q1 | 490 Million INR | 0.0% |
| 2017 Q2 | 1.47 Billion INR | 201.43% |
| 2016 FY | - INR | 22.21% |
| 2015 FY | - INR | -11.8% |
| 2014 FY | - INR | 0.0% |